Reports Outline Ovarian Cancer Study Results from Yale University [The Poly (Adp-ribose) Polymerase Inhibitor Olaparib and Pan-erbb Inhibitor Neratinib Are Highly Synergistic In Her2 Overexpressing Epithelial Ovarian Carcinoma In Vitro and In ...]

Press/Media

Period20 Mar 2023

Media coverage

1

Media coverage

  • TitleReports Outline Ovarian Cancer Study Results from Yale University [The Poly (Adp-ribose) Polymerase Inhibitor Olaparib and Pan-erbb Inhibitor Neratinib Are Highly Synergistic In Her2 Overexpressing Epithelial Ovarian Carcinoma In Vitro and In ...]
    Media name/outletNewsRx Women's Health Daily
    Country/TerritoryUnited States
    Date20/03/23
    PersonsPeter Dottino, Yang Yang